SQUAMOUS NON SMALL CELL LUNG CANCER (NSCLC-SCC)

Clinical trials for SQUAMOUS NON SMALL CELL LUNG CANCER (NSCLC-SCC) explained in plain language.

Never miss a new study

Get alerted when new SQUAMOUS NON SMALL CELL LUNG CANCER (NSCLC-SCC) trials appear

Sign up with your email to follow new studies for SQUAMOUS NON SMALL CELL LUNG CANCER (NSCLC-SCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New cancer drug enters human testing for Hard-to-Treat tumors

Disease control Ongoing

This is the first human trial testing a new cancer drug called GEN1047 in people with advanced solid tumors, including breast, ovarian, endometrial, and a type of lung cancer. The main goals are to find a safe dose and see if the drug helps shrink tumors. All 179 participants wil…

Matched conditions: SQUAMOUS NON SMALL CELL LUNG CANCER (NSCLC-SCC)

Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

SQUAMOUS NON SMALL CELL LUNG CANCER (NSCLC-SCC)

Get alerted when new SQUAMOUS NON SMALL CELL LUNG CANCER (NSCLC-SCC) trials appear

New cancer drug enters human testing for Hard-to-Treat tumors